Potenciální terapeutické přístupy u buněk CML rezistentních na TKI léky.
The therapy of common haematological malignancy chronic myeloid leukaemia (CML) has dramatically improved patient prognosis upon approval of selective tyrosine kinase inhibitor (TKI) imanitib. However, subset of patients develops resistance to imanitib, which limits its therapeutic potential. We der...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Dissertation |
| Language: | Czech |
| Published: |
2013
|
| Online Access: | http://www.nusl.cz/ntk/nusl-321150 |